Alternatively, the marked cytotoxic attack against tumor cells leads to the exposure of numerous host antigens and the potential generation of autoreactive CD4+/CD8+ T cells that target cross-reactive dermal/epidermal self-antigens, which have not yet been identified. This evidence concerns the gene CD4 and neoplasm.